| Vessel co-option in cancer EA Kuczynski, PB Vermeulen, F Pezzella, RS Kerbel, AR Reynolds Nature reviews Clinical oncology 16 (8), 469-493, 2019 | 417 | 2019 |
| Drug rechallenge and treatment beyond progression—implications for drug resistance EA Kuczynski, DJ Sargent, A Grothey, RS Kerbel Nature reviews Clinical oncology 10 (10), 571-587, 2013 | 288 | 2013 |
| Vessel co‐option is common in human lung metastases and mediates resistance to anti‐angiogenic therapy in preclinical lung metastasis models VL Bridgeman, PB Vermeulen, S Foo, A Bilecz, F Daley, E Kostaras, ... The Journal of pathology 241 (3), 362-374, 2017 | 213 | 2017 |
| Co-option of liver vessels and not sprouting angiogenesis drives acquired sorafenib resistance in hepatocellular carcinoma EA Kuczynski, M Yin, A Bar-Zion, CR Lee, H Butz, S Man, F Daley, ... Journal of the National Cancer Institute 108 (8), djw030, 2016 | 181 | 2016 |
| Non-angiogenic tumours and their influence on cancer biology T Donnem, AR Reynolds, EA Kuczynski, K Gatter, PB Vermeulen, ... Nature Reviews Cancer 18 (5), 323-336, 2018 | 155 | 2018 |
| Vessel co-option and resistance to anti-angiogenic therapy EA Kuczynski, AR Reynolds Angiogenesis 23 (1), 55-74, 2020 | 114 | 2020 |
| Effects of sorafenib dose on acquired reversible resistance and toxicity in hepatocellular carcinoma EA Kuczynski, CR Lee, S Man, E Chen, RS Kerbel Cancer research 75 (12), 2510-2519, 2015 | 92 | 2015 |
| Release of endothelial cell associated VEGFR2 during TGF-β modulated angiogenesis in vitro M Jarad, EA Kuczynski, J Morrison, AM Viloria-Petit, BL Coomber BMC Cell Biology 18, 1-10, 2017 | 69 | 2017 |
| Combination of dual mTORC1/2 inhibition and immune-checkpoint blockade potentiates anti-tumour immunity S Langdon, A Hughes, MA Taylor, EA Kuczynski, DA Mele, O Delpuech, ... Oncoimmunology 7 (8), e1458810, 2018 | 52 | 2018 |
| VEGFR2 expression and TGF-β signaling in initial and recurrent high-grade human glioma EA Kuczynski, SG Patten, BL Coomber Oncology 81 (2), 126-134, 2011 | 41 | 2011 |
| Feline programmed death and its ligand: characterization and changes with feline immunodeficiency virus infection A Folkl, X Wen, E Kuczynski, ME Clark, D Bienzle Veterinary Immunology and Immunopathology 134 (1-2), 107-114, 2010 | 38 | 2010 |
| Impact of chemical-induced mutational load increase on immune checkpoint therapy in poorly responsive murine tumors EA Kuczynski, J Krueger, A Chow, P Xu, S Man, Y Sundaravadanam, ... Molecular cancer therapeutics 17 (4), 869-882, 2018 | 29 | 2018 |
| Implications of vessel co-option in sorafenib-resistant hepatocellular carcinoma EA Kuczynski, RS Kerbel Chinese Journal of Cancer 35 (1), 97, 2016 | 28 | 2016 |
| Colorectal carcinoma cell production of transforming growth factor beta decreases expression of endothelial cell vascular endothelial growth factor receptor 2 EA Kuczynski, AM Viloria‐Petit, BL Coomber Cancer 117 (24), 5601-5611, 2011 | 18 | 2011 |
| A preclinical model of peripheral T‐cell lymphoma GATA3 reveals DNA damage response pathway vulnerability EA Kuczynski, G Morlino, A Peter, AML Coenen‐Stass, JI Moss, N Wali, ... EMBO Molecular Medicine 14 (6), e15816, 2022 | 3 | 2022 |
| Longitudinal tracking of T cell lymphomas in mice using flow cytometry EA Kuczynski, L Carnevalli, C Sinclair STAR protocols 4 (2), 102144, 2023 | 2 | 2023 |
| AZD0171 (anti-LIF) combines productively with chemotherapy and anti-PD-L1 in mouse models of cancer J Candido, G Kar, B Zhang, G Opoku-Ansah, A Grover, EA Kuczynski, ... Cancer Research 82 (12_Supplement), 1293-1293, 2022 | 2 | 2022 |
| Mechanisms of reversible sorafenib resistance in hepatocellular carcinoma EA Kuczynski University of Toronto (Canada), 2016 | 1 | 2016 |
| Abstract PO-20: Molecular characterization of a mouse model of peripheral T-cell lymphoma with Tfh and Th2 features E Kuczynski, G Morlino, A Peter, D Calado, C Sinclair, L Carnevalli Blood Cancer Discovery 1 (3_Supplement), PO-20-PO-20, 2020 | | 2020 |
| 薬剤の再投与と増悪後の継続投与: 薬剤耐性の重要性 EA Kuczynski, DJ Sargent, A Grothey Nature reviews. Cancer, clinical oncology 4 (1), 16-33, 2014 | | 2014 |
